These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 22821812)

  • 21. Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals.
    Hiraga T; Nakamura H
    Int J Cancer; 2009 Jan; 124(1):215-22. PubMed ID: 18814279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
    Abouantoun TJ; MacDonald TJ
    Mol Cancer Ther; 2009 May; 8(5):1137-47. PubMed ID: 19417143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma.
    Beckermann BM; Kallifatidis G; Groth A; Frommhold D; Apel A; Mattern J; Salnikov AV; Moldenhauer G; Wagner W; Diehlmann A; Saffrich R; Schubert M; Ho AD; Giese N; Büchler MW; Friess H; Büchler P; Herr I
    Br J Cancer; 2008 Aug; 99(4):622-31. PubMed ID: 18665180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression.
    Beppu K; Jaboine J; Merchant MS; Mackall CL; Thiele CJ
    J Natl Cancer Inst; 2004 Jan; 96(1):46-55. PubMed ID: 14709738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice.
    Pirson L; Baron F; Meuris N; Giet O; Castermans E; Greimers R; Di Stefano I; Gothot A; Beguin Y
    Stem Cells; 2006 Jul; 24(7):1814-21. PubMed ID: 16614006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential roles of growth factor PDGF-BB in the bony repair of injured growth plate.
    Chung R; Foster BK; Zannettino AC; Xian CJ
    Bone; 2009 May; 44(5):878-85. PubMed ID: 19442606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
    Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
    J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
    Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T
    J Neurosurg; 2012 Oct; 117(4):697-704. PubMed ID: 22900848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
    Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
    J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
    Peng Y; Li Z; Li Z
    Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
    Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
    Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells.
    Kanehira M; Xin H; Hoshino K; Maemondo M; Mizuguchi H; Hayakawa T; Matsumoto K; Nakamura T; Nukiwa T; Saijo Y
    Cancer Gene Ther; 2007 Nov; 14(11):894-903. PubMed ID: 17693990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer.
    Kikuchi H; Yagi H; Hasegawa H; Ishii Y; Okabayashi K; Tsuruta M; Hoshino G; Takayanagi A; Kitagawa Y
    J Surg Res; 2014 Jul; 190(1):134-43. PubMed ID: 24679698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
    Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
    J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.
    Takigawa H; Kitadai Y; Shinagawa K; Yuge R; Higashi Y; Tanaka S; Yasui W; Chayama K
    Neoplasia; 2017 May; 19(5):429-438. PubMed ID: 28433772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas.
    Bexell D; Gunnarsson S; Tormin A; Darabi A; Gisselsson D; Roybon L; Scheding S; Bengzon J
    Mol Ther; 2009 Jan; 17(1):183-90. PubMed ID: 18985030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
    Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
    Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.